NeuroOne Medical Technologies (NASDAQ:NMTC) Announces Earnings Results

NeuroOne Medical Technologies (NASDAQ:NMTCGet Free Report) announced its earnings results on Tuesday. The company reported ($0.11) earnings per share for the quarter, Zacks reports. NeuroOne Medical Technologies had a negative net margin of 308.51% and a negative return on equity of 276.12%.

NeuroOne Medical Technologies Price Performance

NeuroOne Medical Technologies stock opened at $0.79 on Wednesday. NeuroOne Medical Technologies has a 1-year low of $0.55 and a 1-year high of $1.72. The company’s 50-day moving average is $0.82 and its 200 day moving average is $0.84.

About NeuroOne Medical Technologies

(Get Free Report)

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.

Read More

Earnings History for NeuroOne Medical Technologies (NASDAQ:NMTC)

Receive News & Ratings for NeuroOne Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroOne Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.